Coronavirus and your health

Learn more about COVID-19 and diabetes.   |   Precautions for patients facing higher risks

Management and Treatment of Diabetes to Prevent Cardiovascular

In a recent survey of people age 45 and older with T2D, only about half recognize their risk or have discussed their risk for heart attacks or strokes with their healthcare providers. Drs. Christopher Cannon and Ronald Goldberg will discuss the management and treatment of diabetes to prevent cardiovascular disease in the new American Diabetes Association’s 2019 Standards of Care.

Play the podcast in Apple Podcasts.

podcast player graphic

Episode 2 – Management and Treatment of Diabetes to Prevent Cardiovascular

Download the Episode 2 Transcript.

Christopher P. Cannon, MD is a Professor of Medicine at Harvard Medical School, and senior physician in the Cardiovascular Division at Brigham and Women’s Hospital. Dr. Cannon is currently working on clinical trials, registries and quality improvement projects in the fields of acute coronary syndromes, atrial fibrillation, diabetes, lipids and prevention, and has published over 1000 original articles, reviews or book chapters in the field of acute coronary syndromes and prevention and has authored or edited 18 books.

Christopher P. Cannon, MD

Christopher P. Cannon, MD

Ronald Goldberg, MD is a Professor of Medicine, Biochemistry, and Molecular Biology in the Division of Endocrinology, Diabetes and Metabolism at the University of Miami Miller School of Medicine. His research interests are in the prevention and early phases of development of diabetes and its complications with a special focus on the evolution of cardiovascular risk and disease in diabetes and in the metabolism and clinical relevance of HDL. His clinical and teaching interests are in the area of diabetes and lipid disorders.

Ronald Goldberg, MD

Ronald Goldberg, MD